BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29301508)

  • 1. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.
    Fonseca PFS; Cançado RD; Naoum FA; Dinardo CL; Fonseca GHH; Gualandro SFM; Krieger JE; Pereira AC; Brissot P; Santos PCJL
    BMC Med Genet; 2018 Jan; 19(1):3. PubMed ID: 29301508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.
    Acevedo LAU; Alvarenga AM; Fonseca PFS; da Silva NK; Cançado RD; Naoum FA; Dinardo CL; Pereira AC; Brissot P; Santos PCJL
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R; Romeril K; Bromhead C
    Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
    Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
    J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemochromatosis.
    Crownover BK; Covey CJ
    Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
    Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
    J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
    Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
    Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
    Harrison HF; Harrison BW; Walker AP; Lohman K; Ellis SD; Hall MA; Reiss J; Adams PC; Holup J; Acton RT; Bent T; Rivers C; Fadojutimi-Akinsiku M
    Genet Test; 2008 Dec; 12(4):491-500. PubMed ID: 18939938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.
    Scotet V; Saliou P; Uguen M; L'Hostis C; Merour MC; Triponey C; Chanu B; Nousbaum JB; Le Gac G; Ferec C
    BMC Pregnancy Childbirth; 2018 Feb; 18(1):53. PubMed ID: 29454332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren CE; Gordeuk VR; Chen WP; Barton JC; Acton RT; Speechley M; Castro O; Adams PC; Snively BM; Harris EL; Reboussin DM; McLachlan GJ; Bean R;
    Transl Res; 2008 Feb; 151(2):97-109. PubMed ID: 18201677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.